Biomedical
Wendy Levinson
Peer Reviewed
Physicians know how easy it is to start a medication for a chronic condition in older adults. Often, these medications have marginal benefits and substantial potential harms and can be difficult to stop once started. Many older patients receive multiple medications with potential interactions and harms, which can be costly and is sometimes referred to as financial toxicity from treatment. Yet the problems of polypharmacy and overprescribing in older adults remain stubbornly difficult to address despite the many well-meaning attempts at a solution that targets prescribers and patients.
The article emphasizes the importance of evaluating the benefits and risks of medications in older adults, advocating for a patient-centered approach to prescribing and deprescribing.
The author suggests that healthcare professionals engage in shared decision-making with patients, considering factors such as life expectancy, quality of life, and individual preferences to ensure that prescribed medications align with the patient's values and goals.
Adopting this approach can minimize polypharmacy, reduce the potential for adverse drug events, and enhance the overall well-being of older adults by ensuring that medications are appropriate and beneficial for each individual.
Show by month | Manuscript | Video Summary |
---|---|---|
2025 February | 10 | 10 |
2025 January | 159 | 159 |
2024 December | 56 | 56 |
2024 November | 55 | 55 |
2024 October | 25 | 25 |
Total | 305 | 305 |
Show by month | Manuscript | Video Summary |
---|---|---|
2025 February | 10 | 10 |
2025 January | 159 | 159 |
2024 December | 56 | 56 |
2024 November | 55 | 55 |
2024 October | 25 | 25 |
Total | 305 | 305 |